Arthur P. Bertolino
2014
In 2014, Arthur P. Bertolino earned a total compensation of $2.6M as Executive Vice President and Chief Medical Officer at Revance Therapeutics.
Compensation breakdown
Bonus | $50,000 |
---|---|
Non-Equity Incentive Plan | $35,249 |
Option Awards | $1,477,236 |
Salary | $129,182 |
Stock Awards | $904,444 |
Total | $2,596,110 |
Bertolino received $1.5M in option awards, accounting for 57% of the total pay in 2014.
Bertolino also received $50K in bonus, $35.2K in non-equity incentive plan, $129.2K in salary and $904.4K in stock awards.
Rankings
In 2014, Arthur P. Bertolino's compensation ranked 3,515th out of 13,032 executives tracked by ExecPay. In other words, Bertolino earned more than 73.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,515 out of 13,032 | 73rd |
Division Manufacturing | 1,239 out of 4,966 | 75th |
Major group Chemicals And Allied Products | 401 out of 1,686 | 76th |
Industry group Drugs | 311 out of 1,365 | 77th |
Industry Pharmaceutical Preparations | 253 out of 1,043 | 76th |
Source: SEC filing on March 26, 2015.
Bertolino's colleagues
We found three more compensation records of executives who worked with Arthur P. Bertolino at Revance Therapeutics in 2014.